Study: NCT04452838

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)
Description: 4 mg administered under fasted condition.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
Description: 4 mg administered under fasted conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
Description: 4 mg administered under fasted conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
Description: 4 mg administered under fasted conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
Description: 4 mg administered under fasted conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
Description: 4 mg administered under fasted conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
Description: 4 mg administered under fasted conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
Description: 4 mg administered under fed conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
Description: 4 mg administered under fed conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
Description: 4 mg administered under fed conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
Description: 4 mg administered under fed conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
Description: 4 mg administered under fed conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
Description: 4 mg administered under fed conditions.

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 on apple sauce (Treatment D in Part A)
Description: 4 mg sprinkled on apple sauce administered under fasting conditions

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR7 on apple sauce (Treatment D in Part A)
Description: 4 mg sprinkled on apple sauce administered under fasting conditions

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR4 fed (Treatment E in Part B)
Description: 4 mg administered under fed conditions

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR4 fed (Treatment E in Part B)
Description: 4 mg administered under fed conditions

Intervention type: DRUG
Group type: OTHER
Intervention: Fesoterodine BIC SR4 fed (Treatment E in Part B)
Description: 4 mg administered under fed conditions